Publications by authors named "Robert Hast"

Claim this Profile
S
Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes.
Harriet Ryblom, Robert Hast, Eva Hellström-Lindberg, Jeanette Winterling, Eva Johansson

Eur J Oncol Nurs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early landmark analysis of imatinib treatment in CML chronic phase: less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome.
Lotta Ohm, Ingrid Arvidsson, Gisela Barbany, Robert Hast, Leif Stenke

Am J Hematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution.
Maciej Machaczka, Robert Hast, Ingrid Dahlman, Richard Lerner, Monika Klimkowska

Ups J Med Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.
Marit Mejhert, Robert Hast, Benngt Sandstedt, Izabella Janczewska

BMJ Case Rep· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Robert Hast

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent malignant stem cells in del(5q) myelodysplasia in remission.
Ramin Tehranchi, Petter S Woll, Kristina Anderson, Natalija Buza-Vidas, Takuo Mizukami, Robert Hast

N Engl J Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia.
Eva Johansson, Per Engervall, Hjördis Björvell, Robert Hast, Magnus Björkholm

Support Care Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Aquagenic pruritus from polycythaemia vera--treatment with paroxetine, a selective serotonin reuptake inhibitor].
Thomas Kümler, Daniel Hedlund, Robert Hast, Hans C Hasselbalch

Ugeskr Laeger· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.
Lars Nilsson, Patrik Edén, Eleonor Olsson, Robert Månsson, Ingbritt Astrand-Grundström, Robert Hast

Blood· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Ulla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, Inger Braide, Karin Carlson, Robert Hast

Leuk Lymphoma· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Per Anders Broliden, Inger-Marie Dahl, Robert Hast, Bertil Johansson, Eeva Juvonen

Haematologica· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
Ramin Tehranchi, Bengt Fadeel, Jan Schmidt-Mende, Ann-Mari Forsblom, Emma Emanuelsson, Robert Hast

Clin Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
Ramin Tehranchi, Rosangela Invernizzi, Alf Grandien, Boris Zhivotovsky, Bengt Fadeel, Robert Hast

Blood· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Bengt Simonsson, Gunnar Oberg, Mats Bjoreman, Magnus Bjorkholm, Jan Carneskog, Robert Hast

Acta Haematol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Ulla Olsson-Strömberg, Bengt Simonsson, Tomas Ahlgren, Magnus Björkholm, Karin Carlsson, Robert Hast

Hematol J· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Honar Cherif, Magnus Björkholm, Per Engervall, Peter Johansson, Per Ljungman, Robert Hast

Scand J Infect Dis· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study.
Eva Johansson, Magnus Björkholm, Hjördis Björvell, Robert Hast, Rabbe Takolander

Support Care Cancer· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
Helene Hallböök, Bengt Simonsson, Thomas Ahlgren, Magnus Björkholm, Jan Carneskog, Robert Hast

Br J Haematol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Lars Nilsson, Ingbritt Astrand-Grundström, Kristina Anderson, Ingrid Arvidsson, Peter Hokland, Robert Hast

Blood· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies.
Kristina Anderson, Ingrid Arvidsson, Björn Jacobsson, Robert Hast

Cancer Genet Cytogenet· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course.
Viktoria Hjalmar, Robert Hast, Eva Kimby

Eur J Haematol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes.
Jonas Wallvik, Leif Stenke, Per Bernell, Gunnar Nordahl, Erik Hippe, Robert Hast

Eur J Haematol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis